Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 9926 - 9950 of 11076 in total
AT132 is under investigation in clinical trial NCT03199469 (Gene Transfer Clinical Study in X-linked Myotubular Myopathy).
Investigational
Mapracorat has been investigated for the treatment of Eczema and Atopic Dermatitis.
Investigational
Matched Iupac: … (2R)-4-(5-fluoro-2,3-dihydro-1-benzofuran-7-yl)-4-methyl-1-[(2-methylquinolin-5-yl)amino]-2-(trifluoromethyl …
Experimental
Matched Iupac: … (1S,2R,10R,11S,14S,15S)-14-(cyclopent-1-en-1-yloxy)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca …
Experimental
Matched Iupac: … methyl 7-[(1S,2S,3S)-3-hydroxy-2-[(1E,3S)-3-hydroxy-4-phenoxybut-1-en-1-yl]-5-oxocyclopentyl]hepta-4,5 …
Experimental
Matched Iupac: … 4-{[(3R)-3-(2-cyclohexanesulfonamidoacetamido)-4-oxo-4-(piperidin-1-yl)butyl]amino}pyridin-1-ium …
Enrofloxacin is an antibiotic agent from the fluoroquinolone family produced by the Bayer Corporation. Enrofloxacin is approved by the FDA for its veterinary use. Due to the identification of fluoroquinolone-resistant strains of Campylobacter, in September 2005, the FDA withdrew the approval of enrofloxacin for its use in water to treat...
Vet approved
Matched Iupac: … 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid …
Tallimustine, a benzoyl mustard derivative of distamycin A, is an alkylating agent that binds to the minor groove of DNA.[A182036,A182039] It's association with severe myelotoxicity lead to the end of its development in favour of α-halogenoacrylamide derivatives such as brostallicin, which have a favourable cytotoxicity/myelotoxicity ratio.[A182039,A182045] Newer generations of DNA...
Experimental
Matched Iupac: … -3-yl}carbamoyl)-1-methyl-1H-pyrrol-3-yl]-1-methyl-1H-pyrrole-2-carboxamide ... 4-{4-[bis(2-chloroethyl)amino]benzamido}-N-[5-({5-[(2-carbamimidoylethyl)carbamoyl]-1-methyl-1H-pyrrol …
Investigational
Matched Iupac: … 2-amino-N-[(2R)-1-[(3R)-3-benzyl-3-(N,N',N'-trimethylhydrazinecarbonyl)piperidin-1-yl]-3-(1H-indol-3- ... yl)-1-oxopropan-2-yl]-2-methylpropanamide …
Investigational
Investigational
A sympathomimetic agent that was formerly used as an anorectic. It has properties similar to those of dextroamphetamine. It has been implicated in lipid storage disorders and pulmonary hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1223)
Illicit
Withdrawn
Matched Iupac: … 1-(4-chlorophenyl)-2-methylpropan-2-amine …
Experimental
Matched Iupac: … [(1R)-1-amino-3-methylbutyl]phosphonic acid …
Experimental
Matched Iupac: … (2S)-2-amino-2-carboxyethan-1-aminium …
Experimental
Matched Iupac: … 1-(4-methylbenzenesulfonyl)-3-(4-sulfamoylphenyl)urea …
Experimental
Matched Iupac: … (3S)-3-amino-1-azacyclotridecan-2-one …
Fenamole has been investigated for the supportive care of Side Effects and Dental Plaque.
Investigational
Matched Iupac: … 1-phenyl-1H-1,2,3,4-tetrazol-5-amine …
Experimental
Matched Iupac: … {1-azabicyclo[2.2.2]octan-3-yl}diphenylmethanol …
Experimental
Matched Iupac: … (3-chloropropyl)(1-phenylpropan-2-yl)amine …
Experimental
Matched Iupac: … (9Z)-octadec-9-en-1-amine hydrofluoride …
Experimental
Illicit
Matched Iupac: … 4,4-diphenyl-6-(piperidin-1-yl)heptan-3-one …
An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. [PubChem]
Experimental
Illicit
Matched Iupac: … 1-(2H-1,3-benzodioxol-5-yl)propan-2-amine …
Experimental
Matched Iupac: … 4-[(6-aminopyrimidin-4-yl)amino]benzene-1-sulfonamide …
Perifosine is a novel alkylphospholipid with antiproliferative properties attributed to protein kinase B inhibition.
Investigational
Matched Iupac: … 1,1-dimethyl-4-{[(octadecyloxy)phosphinato]oxy}piperidin-1-ium …
Experimental
Matched Iupac: … [(1S,3R,7R)-1-hydroxy-3,7,11-trimethyldodecyl]phosphonic acid …
Displaying drugs 9926 - 9950 of 11076 in total